本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

24.14
-0.0300-0.12%
盤後24.240.1000+0.41%19:30 EDT
成交量:66.35萬
成交額:1,609.08萬
市值:27.12億
市盈率:-14.18
高:24.62
開:24.41
低:24.06
收:24.17
52周最高:34.72
52周最低:15.96
股本:1.12億
流通股本:9,711.04萬
量比:0.79
換手率:0.68%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
淨資產收益率:-26.91%
總資產收益率:-14.75%
市淨率:4.47
市盈率(LYR):-15.06

資料載入中...

2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2021/01/06

重要事件披露

8-K - Current report
2021/01/04

重要事件披露

8-K - Current report
2020/12/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/18

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/18

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/08/13

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/06/17

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/29

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals